Hřib claims that Prague is ready for the micro
The boletus is provided to the omicron. According to him, it is already massively occurring in the Czech Republic. It is important to keep it under control so that hospitals do not get overwhelmed.
The mayor of Prague, Zdeněk Hřib (Pirates), stated that omicron is already massively occurring in the Czech Republic. Highly infectious variant of omicron, which scientists first captured in South Africa, has already spread to dozens of countries. Outside the country, omicron is spreading in Western Europe and the USA. Airlines cancel thousands of flights.
We have to guard hospitals
“The omicron variant is already spreading massively in the Czech Republic. Around the middle of December, we have such a phenomenon, which we encounter whenever another wave begins with the help of a new mutation. This means that the share of newly infected in Prague will exceed 10 percent the total number of positively tested in the whole Czech Republic, “ quoted the portal Next Mayor Hřiby.
“Our task is to guard the hospitals that the regions often run. In Prague, hospitals are primarily state-owned, however, we are in contact with them. The second thing that is newly added to the omikron variant is provision of staff for basic public services. The rate of spread of the epidemic is faster with this mutation, so not only can the hospital be stopped, but also problems in this area. “ quotes Reflex Mushroom.
In addition to Western Europe and the United States, where omicro is already prevalent, there are also problems in Australia. New South Wales announced on December 26 record daily gains infected, namely 6394. There is also a huge problem in air transport, as airlines are now canceling thousands of years.
It circumvents immunity
According to experts, omicron is specific in that it resembles virosis. Causes colds, sore throats and colds. The main difference, however, is his ability to bypass immunity built up by vaccination. This fact is described in a new study by Columbia University researchers published in the journal Nature.
The study reports that antibodies from the most available vaccines, such as Moderna, Pfizer, AstraZeneca and Johnson & Johnson, are less effective against the omicron mutation than against the original virus. Immunity only worked in people with a strengthening third dose. Monoclonal antibodies are also ineffective. The good news, however, is that two other independent studies confirm that it represents about 67 percent less risk of hospitalization than delta.